Matches in Wikidata for { <http://www.wikidata.org/entity/Q74835081> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q74835081 description "artículu científicu espublizáu en xunetu de 1998" @default.
- Q74835081 description "im Juli 1998 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74835081 description "scientific article published on 01 July 1998" @default.
- Q74835081 description "wetenschappelijk artikel" @default.
- Q74835081 description "наукова стаття, опублікована в липні 1998" @default.
- Q74835081 name "Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease" @default.
- Q74835081 name "Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease" @default.
- Q74835081 type Item @default.
- Q74835081 label "Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease" @default.
- Q74835081 label "Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease" @default.
- Q74835081 prefLabel "Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease" @default.
- Q74835081 prefLabel "Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease" @default.
- Q74835081 P1433 Q74835081-C9292338-148B-40B9-B4D4-C6CA7E7C3894 @default.
- Q74835081 P1476 Q74835081-F3BC2018-5823-4585-BCD6-CF52CC3DB05C @default.
- Q74835081 P2093 Q74835081-93970C1A-98D0-497C-B8FC-36A5677C2C56 @default.
- Q74835081 P2093 Q74835081-95FF9E07-0662-461B-9186-51974FF80D88 @default.
- Q74835081 P2093 Q74835081-A18BC0D1-47C4-49A0-9CD7-870C2F2D0593 @default.
- Q74835081 P2093 Q74835081-FEC78272-1E8E-49C4-BAF6-AC7703596035 @default.
- Q74835081 P304 Q74835081-6DF474F5-9A80-4FAC-AFC1-2B8C6DD4F4EF @default.
- Q74835081 P31 Q74835081-34BE2846-6A90-460F-9307-5A902C7D1EC0 @default.
- Q74835081 P433 Q74835081-4D6CC99C-3604-48CA-BA2F-86D567498A52 @default.
- Q74835081 P478 Q74835081-BEE28EC3-7239-46E6-8DF6-CA75D96197A2 @default.
- Q74835081 P50 Q74835081-91C5AD7C-0653-454A-BD64-E6B87F890281 @default.
- Q74835081 P50 Q74835081-DC5ED411-C5FA-458F-B7BE-6188C19FBDB5 @default.
- Q74835081 P577 Q74835081-4C5B7D2C-0F4B-4DD5-987A-5520F918D9F3 @default.
- Q74835081 P698 Q74835081-DD98A2BB-48EB-4117-8366-25175299D800 @default.
- Q74835081 P921 Q74835081-60E1174B-C489-485C-A3DE-C648A425CCCC @default.
- Q74835081 P698 9689984 @default.
- Q74835081 P1433 Q27714220 @default.
- Q74835081 P1476 "Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease" @default.
- Q74835081 P2093 "Einzig AI" @default.
- Q74835081 P2093 "Frank M" @default.
- Q74835081 P2093 "Friedenberg W" @default.
- Q74835081 P2093 "Sparano J" @default.
- Q74835081 P304 "254-260" @default.
- Q74835081 P31 Q13442814 @default.
- Q74835081 P433 "4" @default.
- Q74835081 P478 "4" @default.
- Q74835081 P50 Q100309276 @default.
- Q74835081 P50 Q90323603 @default.
- Q74835081 P577 "1998-07-01T00:00:00Z" @default.
- Q74835081 P698 "9689984" @default.
- Q74835081 P921 Q282629 @default.